Mesoblast is in active discussions with US and other government authorities as well as potential pharmaceutical partners with respect to its plans for ramp-up of commercial manufacturing for remestemcel-L in COVID-19 ARDS.2
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
0.000(0.00%) |
Mkt cap ! $2.918B | |||
| Open | High | Low | Value | Volume |
| $2.26 | $2.31 | $2.25 | $3.551M | 1.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 87248 | $2.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 81308 | 25 |
View Market Depth
| Last trade - 15.58pm 12/08/2025 (20 minute delay) ? |
| MSB (ASX) Chart |